Home

Ramtin Agah, Chief Medical Officer: RenovoRx RNXT Buy · Filed 01/05

Trade details

Type
Insider buy
Amount
$8,423.7
Shares · price
9,795 sh · $0.86 a share
Held after
788,460 sh
Trade date
25/12/31
Filed
26/01/05
Days to filing
5 days

First buy since 2023

Insiders buying this week
1 insiders
Holding change
+1.3%

RenovoRx trades, last 26 weeks

What else happened in RenovoRx around then

Filed or reported within 30 days of the trade day · 25/12/01~01/30

Ramtin Agah's recent trades

  • Ramtin Agah

    BuyRenovoRx

    $10K

    Filed 01/22

  • Ramtin Agah

    BuyRenovoRx

    $170

    Filed 01/02

  • Ramtin Agah

    BuyRenovoRx

    $10.2K

    Filed 25/12/17

  • Ramtin Agah

    BuyRenovoRx

    $9,600

    Filed 25/12/08

  • Ramtin Agah

    BuyRenovoRx

    $9,600

    Filed 25/11/24